Novartis divests Miochol-E to prep for Alcon buy
Executive Summary
Bausch & Lomb Inc. has purchased from affiliates of Novartis AG a portion of the Miochol-E (acetylcholine) assets in the US, Canada, Australia, and Korea, as well as parts outside the European Economic Area. It will buy the remainder upon regulatory clearance.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice